Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation

Brian C. Shaffer; Jean-Benoit Le Luduec; Christopher Forlenza; Ann A. Jakubowski; Miguel-Angel Perales; James W. Young; Katharine C. Hsu

doi:10.1016/j.bbmt.2015.12.028

Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.12.028 ◽

2016 ◽

Vol 22 (4) ◽

pp. 705-709 ◽

Cited By ~ 60

Author(s):

Brian C. Shaffer ◽

Jean-Benoit Le Luduec ◽

Christopher Forlenza ◽

Ann A. Jakubowski ◽

Miguel-Angel Perales ◽

...

Keyword(s):

Natural Killer Cell ◽

Natural Killer ◽

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Killer Cell ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Myeloid Malignancies

Download Full-text

Lowering the alemtuzumab dose in reduced intensity conditioning allogeneic hematopoietic cell transplantation is associated with a favorable early intense natural killer cell recovery

Cytotherapy ◽

10.1016/j.jcyt.2013.05.016 ◽

2013 ◽

Vol 15 (10) ◽

pp. 1237-1244 ◽

Cited By ~ 12

Author(s):

Frank Gärtner ◽

Stefanie Hieke ◽

Jürgen Finke ◽

Hartmut Bertz

Keyword(s):

Natural Killer Cell ◽

Natural Killer ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Killer Cell ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Cell Recovery ◽

Reduced Intensity Conditioning ◽

Reduced Intensity

Download Full-text

Natural Killer Cell Therapy in Allogeneic Hematopoietic Cell Transplantation

Blood and Marrow Transplant Handbook ◽

10.1007/978-3-030-53626-8_53 ◽

2021 ◽

pp. 847-857

Author(s):

Jennifer N. Saultz

Keyword(s):

Natural Killer Cell ◽

Cell Therapy ◽

Natural Killer ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Killer Cell ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation

Download Full-text

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

Haematologica ◽

10.3324/haematol.2012.067140 ◽

2012 ◽

Vol 97 (12) ◽

pp. 1882-1889 ◽

Cited By ~ 53

Author(s):

J. Pidala ◽

J. Kim ◽

H. Jim ◽

M. A. Kharfan-Dabaja ◽

T. Nishihori ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Randomized Phase Ii

Download Full-text

Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.05.018 ◽

2015 ◽

Vol 21 (10) ◽

pp. 1770-1775 ◽

Cited By ~ 28

Author(s):

Moshe Yeshurun ◽

Ofer Shpilberg ◽

Corina Herscovici ◽

Liat Shargian ◽

Juliet Dreyer ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Graft Versus Host Disease ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Host Disease ◽

Graft Versus Host

Download Full-text

Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2012.11.119 ◽

2013 ◽

Vol 19 (2) ◽

pp. S158

Author(s):

Lauri Burroughs ◽

Eneida Nemecek ◽

Troy Torgerson ◽

Katherine A. Guthrie ◽

Julie-An Talano ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Malignant Diseases ◽

Preliminary Results

Download Full-text

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

American Journal of Hematology ◽

10.1002/ajh.25035 ◽

2018 ◽

Vol 93 (4) ◽

pp. E96-E98

Author(s):

Dipenkumar Modi ◽

Zaid Al-Kadhimi ◽

Wei Chen ◽

Hyejeong Jang ◽

Abhinav Deol ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Graft Versus Host Disease ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Host Disease ◽

Graft Versus Host ◽

Related Donor

Download Full-text

Detrimental Effect of Natural Killer Cell Alloreactivity in T-replete Hematopoietic Cell Transplantation (HCT) for Leukemia Patients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2006.09.009 ◽

2007 ◽

Vol 13 (2) ◽

pp. 197-205 ◽

Cited By ~ 25

Author(s):

Joel Y. Sun ◽

Andrew Dagis ◽

Laima Gaidulis ◽

Marcia M. Miller ◽

Roberto Rodriguez ◽

...

Keyword(s):

Natural Killer Cell ◽

Natural Killer ◽

Cell Transplantation ◽

Detrimental Effect ◽

Hematopoietic Cell Transplantation ◽

Killer Cell ◽

Hematopoietic Cell

Download Full-text

Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma – a Phase II Study

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00283-9 ◽

2021 ◽

Vol 27 (3) ◽

pp. S228-S229

Author(s):

Carl T. Shultz ◽

Chelby Wakefield ◽

Steven Rollins ◽

Sijin Wen ◽

Lauren Veltri ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Once Daily ◽

Refractory Lymphoma ◽

Reduced Toxicity

Download Full-text

Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2011.12.505 ◽

2012 ◽

Vol 18 (2) ◽

pp. S289-S290

Author(s):

M.L. Sorror ◽

B. Storer ◽

B.M. Sandmaier ◽

T. Chauncey ◽

B. Bruno ◽

...

Keyword(s):

High Risk ◽

Chronic Lymphocytic Leukemia ◽

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Lymphocytic Leukemia ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Early Results

Download Full-text

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study

Haematologica ◽

10.3324/haematol.2011.059378 ◽

2012 ◽

Vol 97 (10) ◽

pp. 1523-1531 ◽

Cited By ~ 75

Author(s):

B. Federmann ◽

M. Bornhauser ◽

C. Meisner ◽

L. Kordelas ◽

D. W. Beelen ◽

...

Keyword(s):

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell Transplantation ◽

Phase Ii Study ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Reduced Intensity Conditioning ◽

Reduced Intensity

Download Full-text